Takafumi Yokota

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications

Development and implementation of a regional medical collaboration platform for hematological malignancies

Development and implementation of a regional medical collaboration platform for hematological malignancies

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: May 13, 2026

Establishment of a patient-derived malignant peripheral nerve sheath tumor organoid model reveals SHH pathway activation and therapeutic vulnerability.

Establishment of a patient-derived malignant peripheral nerve sheath tumor organoid model reveals SHH pathway activation and therapeutic vulnerability.

Journal: Human cell
Published: April 13, 2026

Valemetostat is efficacious against recurrent adult T cell leukemia/lymphoma skin lesions and cutaneous graft-versus-host disease.

Valemetostat is efficacious against recurrent adult T cell leukemia/lymphoma skin lesions and cutaneous graft-versus-host disease.

Journal: Transplantation and cellular therapy
Published: March 25, 2026

Dosing Subcutaneous Immunoglobulin to Achieve Target Levels in Hematopoietic Cell Transplant Recipients.

Dosing Subcutaneous Immunoglobulin to Achieve Target Levels in Hematopoietic Cell Transplant Recipients.

Journal: Blood cell therapy
Published: December 13, 2025

Secondary T-cell lymphoma arising from pre-existing clones in a patient with diffuse large B-cell lymphoma during epcoritamab treatment following CAR-T therapy.

Secondary T-cell lymphoma arising from pre-existing clones in a patient with diffuse large B-cell lymphoma during epcoritamab treatment following CAR-T therapy.

Journal: Haematologica
Published: September 26, 2025

Establishment of human histiocytic sarcoma organoids dependent on the SHH/YAP pathway.

Establishment of human histiocytic sarcoma organoids dependent on the SHH/YAP pathway.

Journal: Human cell
Published: June 25, 2025

Cytogenetic Response to Asciminib in Chronic Myeloid Leukemia With the e19a2 Micro BCR::ABL1 Transcript: A Case Report.

Cytogenetic Response to Asciminib in Chronic Myeloid Leukemia With the e19a2 Micro BCR::ABL1 Transcript: A Case Report.

Journal: Cureus
Published: May 02, 2025

Cross-organ examination of hematologic toxicities from immune checkpoint inhibitors: insights from real-world data.

Cross-organ examination of hematologic toxicities from immune checkpoint inhibitors: insights from real-world data.

Journal: Japanese journal of clinical oncology
Published: February 16, 2025

Clinical Significance of Elevated Levels of Soluble-Form Immune Checkpoint Molecules in Patients With Aggressive Adult T-Cell Leukemia-Lymphoma.

Clinical Significance of Elevated Levels of Soluble-Form Immune Checkpoint Molecules in Patients With Aggressive Adult T-Cell Leukemia-Lymphoma.

Journal: EJHaem
Published: January 24, 2025

Combination of urinary free-glycan markers for the diagnosis of various malignant tumors.

Combination of urinary free-glycan markers for the diagnosis of various malignant tumors.

Journal: Scientific reports
Published: November 07, 2024

Author Correction: A newly identified gene Ahed plays essential roles in murine haematopoiesis.

Author Correction: A newly identified gene Ahed plays essential roles in murine haematopoiesis.

Journal: Nature communications
Published: October 23, 2024

Persistently Low IgG2 Levels in a Subset of Patients Following Hematopoietic Cell Transplantation.

Persistently Low IgG2 Levels in a Subset of Patients Following Hematopoietic Cell Transplantation.

Journal: Clinical transplantation
Published: August 12, 2024
Showing 1-12 of 71

Last Updated: 09/26/2026